THIS
ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED
AND IS NOT FOR PUBLICATION, RELEASE,
DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN
PART, TO ANY US PERSONS OR IN OR INTO THE UNITED STATES, CANADA,
AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER
JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION
WOULD BE UNLAWFUL.
FURTHER, THIS
ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE SEE
THE IMPORTANT NOTICES AT THE END OF THIS
ANNOUNCEMENT.
30 August
2024
MYCELX Technologies
Corporation
("MYCELX" or the
"Company")
Broker Option
MYCELX Technologies Corporation (AIM: MYX), the
clean water and clean air technology company, is pleased to
announce that further to the announcement of the Proposed Placing,
Subscription and Broker Option on 23 August 2024, the Broker Option
has been exercised in respect of 48,543 new Common Shares (the
"Broker Option Shares"),
raising additional gross proceeds of £25,000 (c $33,000) for the
Company.
The Broker Option Shares will be issued at a
price of 51.5 pence per new Common Share (being the Issue Price)
and on the same terms and conditions as the Placing, including the
fact that they are to be issued into the new restricted line of
Common Shares under the symbol MYXR.
The Placing, Subscription and Broker Option
together result in a total gross fundraising of c.$0.93 million
(c.£0.71 million*) for the Company, comprising the Placing raising
c.$0.67 million (c.£0.51 million*), the Subscription raising
c.$0.23 million (c.£0.18 million*), and the Broker Option raising
£25,000 (c.$33,000*) (in each case before expenses).
Admission and
dealings
Application will be made to the London Stock
Exchange for a total of 1,380,791 new Common Shares ("New Common
Shares"), in connection with the Placing, the Subscription and the
Broker Option to be admitted to trading on AIM (the "Admission"). Admission of the Placing
Shares, Subscription Shares and Broker Option Shares is expected to
become effective and dealings commence at 8.00 a.m. on or around 4
September 2024.
The New Common Shares to be issued in connection
with the Placing, Subscription and Broker Option, will when issued
rank pari passu with the
Existing Common Shares, including the right to receive future
dividends.
Upon Admission, the New Common Shares issued
pursuant to the Placing, Subscription and Broker Option will also
trade in the Company's new restricted line of Common Shares under
the symbol MYXR, and the New Common Shares, as represented by
depositary interests ("Depository Interests"), will be held in the
CREST system and will be segregated into a separate trading system
within CREST identified with the marker "REG S" and
USU624551318.
Total Voting
Rights
Following Admission, the total number of Common
Shares in the Company with voting rights is expected to be
24,363,814 with no Common Shares held in treasury. Therefore, the
total number of voting rights in the Company will be 24,363,814
which may be used by shareholders as the denominator for the
calculations by which they determine if they are required to notify
their interest in, or a change to their interest in, the Company
under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.
Terms and definitions used in this announcement
shall have the same meaning as ascribed to them in the Company's
announcements dated 23 August 2024 regarding the Proposed Placing,
Subscription and Broker Option unless otherwise stated.
*Exchange rate of GBP:USD 1.3121 as at 12 noon
on 22 August 2024, the last practicable date prior to the
announcement of the Placing and Subscription.
For further information, please
contact:
MYCELX
Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
|
Tel: +1 888 306 6843
|
Canaccord
Genuity Limited (Nominated Adviser and Sole
Broker)
Henry Fitzgerald-O'Connor
Charlie Hammond
Sam Lucas (ECM)
|
Tel: +44 20 7523 8000
|
Celicourt
Communications (Financial PR)
Mark Antelme
Jimmy Lea
Charlie Denley-Myerson
|
Tel: +44 20 7770 6424
|
IMPORTANT NOTICES
THIS
ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR FORM ANY PART OF AN OFFER TO SELL OR ISSUE, OR A
SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE
ANY SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, THE
REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH
SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO
WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NO PUBLIC
OFFERING OF THE SUBSCRIPTION SHARES OR THE BROKER OPTION SHARES
(TOGETHER, THE "FUNDRAISING SHARES") IS BEING MADE IN ANY SUCH
JURISDICTION. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY
CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF SUCH
JURISDICTIONS.
This Announcement is not for public release,
publication or distribution, in whole or in part, directly or
indirectly, in or into the United States, Canada Australia, the
Republic of South Africa, Japan or any other jurisdiction in which
such release, publication or distribution would be
unlawful.
No action has been taken by the Company,
Canaccord Genuity or any of their respective affiliates, or any of
its or their respective directors, officers, partners, employees,
advisers and/or agents (collectively, "Representatives") that would permit an
offer of any of the Fundraising Shares or possession or
distribution of this Announcement or any other publicity material
relating to such Fundraising Shares in any jurisdiction where
action for that purpose is required. Persons receiving this
Announcement are required to inform themselves about and to observe
any restrictions contained in this Announcement. Persons
(including, without limitation, nominees and trustees) who have a
contractual or other legal obligation to forward a copy of this
Announcement should seek appropriate advice before taking any
action. Persons distributing any part of this Announcement must
satisfy themselves that it is lawful to do so.
Cautionary
Statements Regarding Forward Looking Information
This Announcement contains "forward-looking
information" including as that term is defined under applicable
securities legislation. Such information includes but is not
limited to, the intended use of proceeds, the Fundraising; and the
receipt of required approvals, including the approval of the
shareholders of the Company. Generally, forward-looking information
can be identified by the use of words such as "plans", "expects" or
"is expected", "scheduled", "estimates" "intends", "anticipates",
"believes", or variations of such words and phrases, or statements
that certain actions, events or results "can", "may", "could",
"would", "should", "might" or "will", occur or be achieved, or the
negative connotations thereof. These forward-looking statements are
subject to numerous risks and uncertainties, certain of which are
beyond the control of the Company, which could cause the actual
results, performance or achievements of the Company to be
materially different from the future results, performance or
achievements expressed or implied by such information. These risks
include, without limitation, risks related to Admission and other
applicable securities regulatory authorities, a failure to obtain
adequate financing on a timely basis and on acceptable terms, risks
relating to the Company's ability to respond to technological
advances and emerging industry and regulatory standards and
practices on a cost effective and timely basis, risks relating to
customer diversification, political, regulatory and geopolitical
risks, oil and gas industry cycles, risks relating to the retention
of key personnel, other risks and uncertainties related to the
Company's prospects and business as well as those risk factors
discussed or referred to herein and in the Company's publicly
available information. Although the Company has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking information, there may be other factors that cause
actions, events or results not to be anticipated, estimated or
intended. There can be no assurance that forward-looking statements
will prove to be accurate, as actual results and future events
could differ materially from those anticipated in such information.
The Company undertakes no obligation to update forward-looking
information if circumstances or management's estimates, assumptions
or opinions should change, except as required by applicable law.
The reader is cautioned not to place undue reliance on
forward-looking information. The information in this Announcement
is subject to change.
Canaccord Genuity Limited ("Canaccord Genuity"), which is
authorised and regulated in the United Kingdom by the FCA, is
acting exclusively for the Company and for no one else in
connection with the Fundraising and will not regard any other
person (whether or not a recipient of this Announcement) as a
client in relation to the Fundraising or any other matter referred
to in this Announcement and will not be responsible to anyone other
than the Company in connection with the Fundraising or for
providing the protections afforded to their respective clients or
for giving advice in relation to the Fundraising or any other
matter referred to in this Announcement. Canaccord Genuity's
responsibilities as the Company's nominated adviser under the AIM
Rules for Nominated Advisers are owed solely to the London Stock
Exchange and are not owed to the Company or to any Director or to
any other person.
In connection with the Broker Option, Canaccord
Genuity and any of its affiliates, acting as investors for their
own account, may take up a portion of the Broker Option Shares as a
principal position and in that capacity may retain, purchase, sell,
offer to sell for the own accounts or otherwise deal for their own
account in such shares and other securities of the Company or
related investments in connection with the Broker Option or
otherwise. Accordingly, references to Broker Option Shares being
offered, acquired, placed or otherwise dealt in should be read as
including any issue or offer to, or acquisition, placing or dealing
by Canaccord Genuity and any of its affiliates acting in such
capacity. In addition, Canaccord Genuity and any of its affiliates
may enter into financing arrangements (including swaps) with
investors in connection with which Canaccord Genuity and any of its
affiliates may from time to time acquire, hold or dispose of
shares. Canaccord Genuity does not intend to disclose the extent of
any such investment or transactions otherwise than in accordance
with any legal or regulatory obligations to do so.
This Announcement is being issued by and is the
sole responsibility of the Company. No representation or warranty,
express or implied, is or will be made as to, or in relation to,
and no responsibility or liability is or will be accepted by or on
behalf of Canaccord Genuity (apart from the responsibilities or
liabilities that may be imposed by FSMA or the regulatory regime
established thereunder) and/or by any of their respective
affiliates and/or any of their respective Representatives as to, or
in relation to, the accuracy, adequacy, fairness or completeness of
this Announcement or any other written or oral information made
available to or publicly available to any interested party or their
respective advisers or any other statement made or purported to be
made by or on behalf of Canaccord Genuity and/or any of its
affiliates and/or by any of its Representatives in connection with
the Fundraising and any responsibility and liability whether
arising in tort, contract or otherwise therefor is expressly
disclaimed. No representation or warranty, express or implied, is
made by Canaccord Genuity and/or any of its affiliates and/or any
of its Representatives as to the accuracy, fairness, verification,
completeness or sufficiency of the information or opinions
contained in this Announcement or any other written or oral
information made available to or publicly available to any
interested party or their respective advisers, and any liability
therefor is expressly disclaimed.
The information in this Announcement may not be
forwarded or distributed to any other person and may not be
reproduced in any manner whatsoever. Any forwarding, distribution,
reproduction or disclosure of this Announcement, in whole or in
part, is unauthorised. Failure to comply with this directive may
result in a violation of the Securities Act or the applicable laws
of other jurisdictions.
Any indication in this Announcement of the price
at which the Company's shares have been bought or sold in the past
cannot be relied upon as a guide to future performance. Persons
needing advice should consult an independent financial adviser. No
statement in this Announcement is intended to be a profit forecast
or profit estimate for any period and no statement in this
Announcement should be interpreted to mean that earnings, earnings
per share or income, cash flow from operations or free cash flow
for the Company for the current or future financial periods would
necessarily match or exceed the historical published earnings,
earnings per share or income, cash flow from operations or free
cash flow for the Company.
Neither the content of the Company's website (or
any other website) nor the content of any website accessible from
hyperlinks on the Company's website (or any other website) is
incorporated into, or forms part of, this Announcement.
This Announcement has been prepared for the
purposes of complying with applicable law and regulation in the
United Kingdom and the information disclosed may not be the same as
that which would have been disclosed if this Announcement had been
prepared in accordance with the laws and regulations of any
jurisdiction outside the United Kingdom.
Information to
Distributors
THE
DISTRIBUTION OF THIS ANNOUNCEMENT AND THE OFFERING OF THE
FUNDRAISING SHARES IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY
LAW. NO ACTION HAS BEEN TAKEN BY THE COMPANY, CANACCORD GENUITY OR
ANY OF THEIR RESPECTIVE AFFILIATES THAT WOULD PERMIT AN OFFERING OF
THE FUNDRAISING SHARES OR POSSESSION OR DISTRIBUTION OF THIS
ANNOUNCEMENT OR ANY OTHER OFFERING OR PUBLICITY MATERIAL RELATING
TO THE FUNDRAISING SHARES IN ANY JURISDICTION WHERE ACTION FOR THAT
PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS
ANNOUNCEMENT COMES ARE REQUIRED BY THE COMPANY AND CANACCORD
GENUITY TO INFORM THEMSELVES ABOUT, AND TO OBSERVE, SUCH
RESTRICTIONS.
Persons distributing this Announcement must
satisfy themselves that it is lawful to do so. Persons (including
without limitation, nominees and trustees) who have a contractual
right or other legal obligations to forward a copy of this
Announcement (or any part thereof) should seek appropriate advice
before taking any action.
UK Product
Governance Requirements
Solely for the purposes of the product
governance requirements of Chapter 3 of the FCA Handbook Product
Intervention and Product Governance Sourcebook (the "UK MiFIR Product Governance
Requirements"), and disclaiming all and any liability,
whether arising in tort, contract or otherwise, which any
"manufacturer" (for the purposes of the UK MiFIR Product Governance
Requirements) may otherwise have with respect thereto, the
Fundraising Shares have been subject to a product approval process,
which has determined that the Fundraising Shares are: (i)
compatible with an end target market of retail investors and
investors who meet the criteria of professional clients and
eligible counterparties, each as defined in paragraphs 3.5 and 3.6
of COBS; and (ii) eligible for distribution through all permitted
distribution channels (the "Target
Market Assessment"). Notwithstanding the Target Market
Assessment, distributors should note that: the price of the
Fundraising Shares may decline and investors could lose all or part
of their investment; the Fundraising Shares offer no guaranteed
income and no capital protection; and an investment in the
Fundraising Shares is compatible only with investors who do not
need a guaranteed income or capital protection, who (either alone
or in conjunction with an appropriate financial or other adviser)
are capable of evaluating the merits and risks of such an
investment and who have sufficient resources to be able to bear any
losses that may result therefrom. The Target Market Assessment is
without prejudice to any contractual, legal or regulatory selling
restrictions in relation to the Fundraising. Furthermore, it is
noted that, notwithstanding the Target Market Assessment, each of
Canaccord Genuity will only procure investors who meet the criteria
of professional clients and eligible counterparties.
For the avoidance of doubt, the Target Market
Assessment does not constitute: (a) an assessment of suitability or
appropriateness for the purposes of Chapters 9A or 10A respectively
of COBS; or (b) a recommendation to any investor or group of
investors to invest in, or purchase, or take any other action
whatsoever with respect to the Fundraising Shares. Each distributor
is responsible for undertaking its own target market assessment in
respect of the Fundraising Shares and determining appropriate
distribution channels.